secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAXCYTE, INC. (MXCT)
CIK:        0001287098
Form:       8-K
Filed at:   2024-12-09T23:59:59+00:00
Accession:  0001558370-24-016085
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 2.05, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MaxCyte cuts 15% workforce, raises 2024 core revenue growth guidance to 6-8%
----------------------------------------------------------------------------

- Reduction of 21 positions (~15% of global workforce) approved December 4, 2024.
- Pre-tax charges of ~$0.8M, primarily in Q4 2024; ~$0.3M cash expenditures.
- Annualized cost savings of ~$5.8M expected from January 2025.
- Raises full-year 2024 core revenue guidance to 6-8% growth vs 2023; affirms SPL revenue ~$6M.
- Employee count expected to end 2024 at 116, down from 143 at end of 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1287098/000155837024016085/0001558370-24-016085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1287098/000155837024016085/mxct-20241204x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-016085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer